<DOC>
	<DOCNO>NCT02959411</DOCNO>
	<brief_summary>This study clarify clinical usefulness Tolvaptan therapy patient complicate acute decompensated heart failure hyponatremia ( low blood sodium ) .</brief_summary>
	<brief_title>Tolvaptan Advanced Refractory Heart Failure</brief_title>
	<detailed_description>Despite demonstrate efficacy tolerability , Tolvaptan remain underutilized treatment acute decompensated heart failure ( ADHF ) many center . Post-hoc analysis suggest Tolvaptan may provide optimal outcome patient advanced heart failure ( HF ) include cardiorenal syndrome , mark hyponatremia severe congestion , combination condition . The efficacy Tolvaptan HF patient loop diuretic resistance require inotropic support remain uncertain . The purpose study examine benefit Tolvaptan versus current standard care diuretic therapy patient hospitalize ADHF evidence advance complex HF severe hyponatremia . Patients advance complex disease define suboptimal diuretic response 48 hour period .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Hyponatremia</mesh_term>
	<mesh_term>Tolvaptan</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<criteria>Hospital admission ADHF volume overload evidence ≥ 2 following : Elevated JVP , peripheral edema , ascites , pulmonary rale , congestion chest Xray , elevate NTproBNP &gt; 2000 pg/ml Loop diuretic resistance evidence reduced urine output &lt; 4 litre ( L ) 48 hour . Inadequate clinical response indicate body weight loss &lt; 0.5 kg/day 48 hour despite adequate dos IV loop diuretic ( least 40 mg furosemide daily ) fluid restriction 2 L/24 hour . ≥1 follow precede 48 hour : Potential need inotropic support improve urine output , and/or renal insufficiency ( estimate glomerular filtration rate &lt; 45 mL/min/1.73 m2 ) Serum sodium ≤130 mmol/L ≥18 yearsold Cardiac surgery within 60 day enrollment Cardiac mechanical support Need intravenous pressor support symptomatic hypotension Biventricular pacemaker placement within last 60 day Acute myocardial infarction time hospitalization Hemodynamically significant uncorrected primary cardiac valvular disease Hemofiltration dialysis Known cirrhosis Supine systolic arterial blood pressure le 85 mmHg Refusal inability sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>